Profund Advisors LLC Acquires 3,166 Shares of Intuitive Surgical, Inc. $ISRG

Profund Advisors LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 34,097 shares of the medical equipment provider’s stock after acquiring an additional 3,166 shares during the quarter. Intuitive Surgical makes up 0.6% of Profund Advisors LLC’s holdings, making the stock its 26th largest holding. Profund Advisors LLC’s holdings in Intuitive Surgical were worth $19,311,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of ISRG. Vanguard Group Inc. grew its position in shares of Intuitive Surgical by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after buying an additional 263,828 shares in the last quarter. Capital World Investors grew its position in shares of Intuitive Surgical by 1.5% during the 3rd quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock worth $3,456,223,000 after buying an additional 116,034 shares in the last quarter. Fisher Asset Management LLC grew its position in shares of Intuitive Surgical by 1.1% during the 3rd quarter. Fisher Asset Management LLC now owns 3,889,439 shares of the medical equipment provider’s stock worth $1,739,475,000 after buying an additional 40,702 shares in the last quarter. Amundi grew its position in shares of Intuitive Surgical by 29.7% during the 3rd quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock worth $1,451,362,000 after buying an additional 739,444 shares in the last quarter. Finally, Jennison Associates LLC grew its position in shares of Intuitive Surgical by 11.1% during the 4th quarter. Jennison Associates LLC now owns 3,209,137 shares of the medical equipment provider’s stock worth $1,817,527,000 after buying an additional 321,759 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $439.92 on Tuesday. Intuitive Surgical, Inc. has a 1-year low of $417.74 and a 1-year high of $603.88. The stock’s 50-day moving average is $462.50 and its 200 day moving average is $513.03. The company has a market cap of $155.80 billion, a P/E ratio of 53.32, a PEG ratio of 3.36 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter last year, the company earned $1.81 earnings per share. The firm’s revenue for the quarter was up 23.0% compared to the same quarter last year. On average, analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $446.95, for a total value of $178,780.00. Following the completion of the sale, the executive vice president owned 6,120 shares of the company’s stock, valued at approximately $2,735,334. This trade represents a 6.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 5,647 shares of company stock valued at $2,760,359 over the last 90 days. Company insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of recent research reports. JPMorgan Chase & Co. dropped their price target on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. HSBC dropped their price target on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Mizuho set a $525.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research report on Monday, April 13th. Robert W. Baird increased their price target on Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Finally, Bank of America dropped their price target on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research report on Monday. Nineteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $579.33.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.